MD SB78

Providers ordering prostate-specific antigen (PSA) tests must give patients written information about necessary preparation for accurate test results

Clinical laboratories offering direct-to-consumer PSA testing without a provider order must provide preparation information at least 3 days before scheduled appointments and through in-person education

Clinical laboratories must use FDA-approved testing assays and implement calibration using World Health Organization International Standards or other nationally recognized reference standards

Laboratories must report PSA results in nanograms per milliliter, include reference ranges specific to the assay used, and disclose test methodology, manufacturer, and lot number to ordering providers

Effective date: July 1, 2026